Company Filing History:
Years Active: 2010-2025
Title: Jorg Eder: Innovator in Renal Disease Treatment
Introduction
Jorg Eder is a notable inventor based in Rheinfelden, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of renal diseases. With a total of three patents to his name, Eder's work focuses on innovative therapeutic approaches.
Latest Patents
One of Jorg Eder's latest patents is titled "Uses of piperidinyl-indole derivatives." This invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, specifically targeting conditions such as C3 glomerulopathy (C3G) and IgA nephropathy (IgAN). Another significant patent is "Factor XI antibodies and methods of use," which involves monoclonal antibodies and antigen-binding fragments that bind to human Factor XI and activated Factor XI (Factor XIa). This patent also includes pharmaceutical compositions and methods of treatment that utilize these antibodies.
Career Highlights
Jorg Eder is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing innovative treatments that address critical health issues, particularly in nephrology.
Collaborations
Throughout his career, Eder has collaborated with esteemed colleagues such as Stefan Ewert and Ulrich Hassiepen. These
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.